Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.39 INR | +4.63% | -.--% | -.--% |
2023 | PSBs Reportedly Shelve Deal to Sell Drug Company Loans to NARCL | CI |
2023 | NARCL Reportedly Offers to Buy INR 11,000 million Loans of Parenteral Drugs | CI |
Business Summary
Number of employees: 909
Sales per Business
INR in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 319 | 100.0 % | 122 | 100.0 % | -61.83% |
Sales per region
INR in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 319 | 100.0 % | 122 | 100.0 % | -61.83% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 74 | 01/89/01 | |
Chairman | 70 | 13/83/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | 13/83/13 | |
Director/Board Member | 78 | 31/06/31 | |
Director of Finance/CFO | 74 | 01/89/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,816,300 | 7,058,410 ( 23.67 %) | 0 | 23.67 % |
Company contact information
Parenteral Drugs (India) Ltd.
Shree Ganesh Chambers Navlakha Crossing
452001, Indore
+91 73 1409 2000
http://www.pdindia.comSector
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.21M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- PDPL Stock
- Company Parenteral Drugs (India) Limited